Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Reset all filters
01 1SANOFI WINTHROP INDUSTRIE Gentilly FR
02 1TARO PHARMACEUTICAL INDUSTRIES, LTD. Haifa Bay IL
Reset all filters
01 2Dipotassium clorazepate monohydrate
Reset all filters
01 1France
02 1Israel
Reset all filters
01 2Valid
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Dipotassium Clorazepate Monohydrate
Certificate Number : CEP 2008-170 - Rev 02
Status : Valid
Issue Date : 2024-03-28
Type : Chemical
Substance Number : 898
Dipotassium Clorazepate Monohydrate
Certificate Number : R1-CEP 2009-386 - Rev 01
Status : Valid
Issue Date : 2020-06-22
Type : Chemical
Substance Number : 898
A Clorazepate Dipotassium manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Clorazepate Dipotassium, including repackagers and relabelers. The FDA regulates Clorazepate Dipotassium manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Clorazepate Dipotassium API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Clorazepate Dipotassium manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Clorazepate Dipotassium supplier is an individual or a company that provides Clorazepate Dipotassium active pharmaceutical ingredient (API) or Clorazepate Dipotassium finished formulations upon request. The Clorazepate Dipotassium suppliers may include Clorazepate Dipotassium API manufacturers, exporters, distributors and traders.
click here to find a list of Clorazepate Dipotassium suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Clorazepate Dipotassium CEP of the European Pharmacopoeia monograph is often referred to as a Clorazepate Dipotassium Certificate of Suitability (COS). The purpose of a Clorazepate Dipotassium CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Clorazepate Dipotassium EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Clorazepate Dipotassium to their clients by showing that a Clorazepate Dipotassium CEP has been issued for it. The manufacturer submits a Clorazepate Dipotassium CEP (COS) as part of the market authorization procedure, and it takes on the role of a Clorazepate Dipotassium CEP holder for the record. Additionally, the data presented in the Clorazepate Dipotassium CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Clorazepate Dipotassium DMF.
A Clorazepate Dipotassium CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Clorazepate Dipotassium CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Clorazepate Dipotassium suppliers with CEP (COS) on PharmaCompass.
We have 2 companies offering Clorazepate Dipotassium
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?